PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Psychiatry, Psychosomatic Medicine, and Psychotherapy, University Hospital Frankfurt, Frankfurt/M, Germany.\', \'Clinic and Policlinic for Psychiatry, Psychosomatics and Psychotherapy, University Hospital Würzburg, Würzburg, Germany.\', \'University of Southern Denmark Odense, J.B. Winslows Vey Odense, Denmark.\', \'Department of Pharmacology und Clinical Pharmacy, University Frankfurt, Frankfurt/M, Germany.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1055/a-1717-2381
?:hasPublicationType
?:journal
  • Pharmacopsychiatry
is ?:pmid of
?:pmid
?:pmid
  • 35079985
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.845
?:rankingScore_hIndex
  • 73
is ?:relation_isRelatedTo_publication of
?:title
  • Neuropsychiatric Drugs Against COVID-19: What is the Clinical Evidence?
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all